Loading...
XNASDHCNL
Market cap533mUSD
Dec 23, Last price  
16.09USD
1D
-0.86%
1Q
-9.75%
Jan 2017
-34.24%
Name

Diversified Healthcare Trust

Chart & Performance

D1W1MN
XNAS:DHCNL chart
P/E
—
P/S
2.75
EPS
—
Div Yield, %
0.25%
Shrs. gr., 5y
0.11%
Rev. gr., 5y
4.77%
Revenues
1.41b
+9.87%
148,523,000163,187,000179,806,000188,022,000235,537,000297,780,000339,009,000450,017,000644,842,000761,438,000844,887,000998,773,0001,058,022,0001,074,819,0001,117,164,0001,040,155,0001,632,026,0001,383,212,0001,283,566,0001,410,308,000
Net income
-294m
L+1,244.87%
56,742,00058,705,00066,101,00085,303,000106,511,000109,715,000116,485,000151,419,000135,884,000151,164,000158,637,000123,968,000141,295,000147,610,000286,872,000-83,278,000-134,307,000174,515,000-21,829,000-293,572,000
CFO
10m
P
95,188,000104,222,000112,335,000135,898,000184,460,000209,392,000215,305,000255,559,000283,302,000306,703,000350,901,000405,521,000426,807,000407,050,000392,840,000265,845,000158,544,000-63,323,000-40,353,00010,483,000
Dividend
Aug 15, 20240.39063 USD/sh
Earnings
Feb 24, 2025

Profile

DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA.
URL
https://www.dhcreit.com
IPO date
Oct 06, 1999
Employees
94,754
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,410,308
9.87%
1,283,566
-7.20%
1,383,212
-15.25%
Cost of revenue
1,200,282
1,135,505
1,125,899
Unusual Expense (Income)
NOPBT
210,026
148,061
257,313
NOPBT Margin
14.89%
11.54%
18.60%
Operating Taxes
445
710
1,430
Tax Rate
0.21%
0.48%
0.56%
NOPAT
209,581
147,351
255,883
Net income
(293,572)
1,244.87%
(21,829)
-112.51%
174,515
-229.94%
Dividends
(9,595)
(9,568)
(9,540)
Dividend yield
1.07%
6.21%
1.30%
Proceeds from repurchase of equity
(393)
(171)
1,292,117
BB yield
0.04%
0.11%
-175.72%
Debt
Debt current
700,000
800,000
Long-term debt
2,862,534
2,378,054
2,951,349
Deferred revenue
3,363,482
3,961,124
Other long-term liabilities
240,519
(3,115,979)
(3,715,833)
Net debt
2,486,679
2,264,512
2,901,374
Cash flow
Cash from operating activities
10,483
(40,353)
(63,323)
CAPEX
(299,387)
(227,605)
Cash from investing activities
(202,111)
387,708
242,696
Cash from financing activities
(249,713)
(675,998)
746,723
FCF
237,294
5,551,792
948,526
Balance
Cash
245,939
658,065
634,848
Long term investments
129,916
155,477
215,127
Excess cash
305,340
749,364
780,814
Stockholders' equity
(2,281,579)
409,162
713,402
Invested Capital
7,704,836
5,524,829
5,873,359
ROIC
3.17%
2.59%
3.52%
ROCE
3.87%
2.48%
3.90%
EV
Common stock shares outstanding
238,836
238,314
237,967
Price
3.74
478.23%
0.65
-79.07%
3.09
-25.00%
Market cap
893,247
479.50%
154,141
-79.04%
735,318
-24.93%
EV
3,379,926
6,787,052
8,258,654
EBITDA
494,109
387,586
521,233
EV/EBITDA
6.84
17.51
15.84
Interest
191,775
209,383
255,759
Interest/NOPBT
91.31%
141.42%
99.40%